1,516
Views
25
CrossRef citations to date
0
Altmetric
Research Paper

NUSAP1 influences the DNA damage response by controlling BRCA1 protein levels

, , , , &
Pages 533-543 | Received 10 Oct 2013, Accepted 28 Jan 2014, Published online: 12 Feb 2014

References

  • Huen MS, Sy SM, Chen J. BRCA1 and its toolbox for the maintenance of genome integrity. Nat Rev Mol Cell Biol 2010; 11:138 - 48; http://dx.doi.org/10.1038/nrm2831; PMID: 20029420
  • Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266:66 - 71; http://dx.doi.org/10.1126/science.7545954; PMID: 7545954
  • Xu B, O’Donnell AH, Kim ST, Kastan MB. Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation. Cancer Res 2002; 62:4588 - 91; PMID: 12183412
  • Kim H, Huang J, Chen J. CCDC98 is a BRCA1-BRCT domain-binding protein involved in the DNA damage response. Nat Struct Mol Biol 2007; 14:710 - 5; http://dx.doi.org/10.1038/nsmb1277; PMID: 17643122
  • Starita LM, Parvin JD. The multiple nuclear functions of BRCA1: transcription, ubiquitination and DNA repair. Curr Opin Cell Biol 2003; 15:345 - 50; http://dx.doi.org/10.1016/S0955-0674(03)00042-5; PMID: 12787778
  • Wang B, Matsuoka S, Ballif BA, Zhang D, Smogorzewska A, Gygi SP, Elledge SJ. Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. Science 2007; 316:1194 - 8; http://dx.doi.org/10.1126/science.1139476; PMID: 17525340
  • Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 2000; 10:886 - 95; http://dx.doi.org/10.1016/S0960-9822(00)00610-2; PMID: 10959836
  • Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 1997; 88:265 - 75; http://dx.doi.org/10.1016/S0092-8674(00)81847-4; PMID: 9008167
  • Moynahan ME, Chiu JW, Koller BH, Jasin M. Brca1 controls homology-directed DNA repair. Mol Cell 1999; 4:511 - 8; http://dx.doi.org/10.1016/S1097-2765(00)80202-6; PMID: 10549283
  • Snouwaert JN, Gowen LC, Latour AM, Mohn AR, Xiao A, DiBiase L, Koller BH. BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a brca1 transgene. Oncogene 1999; 18:7900 - 7; http://dx.doi.org/10.1038/sj.onc.1203334; PMID: 10630642
  • Stark JM, Pierce AJ, Oh J, Pastink A, Jasin M. Genetic steps of mammalian homologous repair with distinct mutagenic consequences. Mol Cell Biol 2004; 24:9305 - 16; http://dx.doi.org/10.1128/MCB.24.21.9305-9316.2004; PMID: 15485900
  • Zhong Q, Boyer TG, Chen PL, Lee WH. Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts. Cancer Res 2002; 62:3966 - 70; PMID: 12124328
  • Harper JW, Elledge SJ. The DNA damage response: ten years after. Mol Cell 2007; 28:739 - 45; http://dx.doi.org/10.1016/j.molcel.2007.11.015; PMID: 18082599
  • Huen MS, Chen J. The DNA damage response pathways: at the crossroad of protein modifications. Cell Res 2008; 18:8 - 16; http://dx.doi.org/10.1038/cr.2007.109; PMID: 18087291
  • Raemaekers T, Ribbeck K, Beaudouin J, Annaert W, Van Camp M, Stockmans I, Smets N, Bouillon R, Ellenberg J, Carmeliet G. NuSAP, a novel microtubule-associated protein involved in mitotic spindle organization. J Cell Biol 2003; 162:1017 - 29; http://dx.doi.org/10.1083/jcb.200302129; PMID: 12963707
  • Vanden Bosch A, Raemaekers T, Denayer S, Torrekens S, Smets N, Moermans K, Dewerchin M, Carmeliet P, Carmeliet G. NuSAP is essential for chromatin-induced spindle formation during early embryogenesis. J Cell Sci 2010; 123:3244 - 55; http://dx.doi.org/10.1242/jcs.063875; PMID: 20807801
  • Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER 3rd, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007; 316:1160 - 6; http://dx.doi.org/10.1126/science.1140321; PMID: 17525332
  • Xie P, Li L, Xing G, Tian C, Yin Y, He F, Zhang L. ATM-mediated NuSAP phosphorylation induces mitotic arrest. Biochem Biophys Res Commun 2011; 404:413 - 8; http://dx.doi.org/10.1016/j.bbrc.2010.11.135; PMID: 21130744
  • Emanuele MJ, Elia AE, Xu Q, Thoma CR, Izhar L, Leng Y, Guo A, Chen YN, Rush J, Hsu PW, et al. Global identification of modular cullin-RING ligase substrates. Cell 2011; 147:459 - 74; http://dx.doi.org/10.1016/j.cell.2011.09.019; PMID: 21963094
  • Bogunovic D, O’Neill DW, Belitskaya-Levy I, Vacic V, Yu YL, Adams S, Darvishian F, Berman R, Shapiro R, Pavlick AC, et al. Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival. Proc Natl Acad Sci U S A 2009; 106:20429 - 34; http://dx.doi.org/10.1073/pnas.0905139106; PMID: 19915147
  • Gulzar ZG, McKenney JK, Brooks JD. Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1. Oncogene 2013; 32:70 - 7; http://dx.doi.org/10.1038/onc.2012.27; PMID: 22349817
  • Marie SK, Okamoto OK, Uno M, Hasegawa AP, Oba-Shinjo SM, Cohen T, Camargo AA, Kosoy A, Carlotti CG Jr., Toledo S, et al. Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas. Int J Cancer 2008; 122:807 - 15; http://dx.doi.org/10.1002/ijc.23189; PMID: 17960622
  • Ryu B, Kim DS, Deluca AM, Alani RM. Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression. PLoS One 2007; 2:e594; http://dx.doi.org/10.1371/journal.pone.0000594; PMID: 17611626
  • Satow R, Shitashige M, Kanai Y, Takeshita F, Ojima H, Jigami T, Honda K, Kosuge T, Ochiya T, Hirohashi S, et al. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma. Clin Cancer Res 2010; 16:2518 - 28; http://dx.doi.org/10.1158/1078-0432.CCR-09-2214; PMID: 20388846
  • Wadia PP, Coram M, Armstrong RJ, Mindrinos M, Butte AJ, Miklos DB. Antibodies specifically target AML antigen NuSAP1 after allogeneic bone marrow transplantation. Blood 2010; 115:2077 - 87; http://dx.doi.org/10.1182/blood-2009-03-211375; PMID: 20053754
  • Chen DT, Nasir A, Culhane A, Venkataramu C, Fulp W, Rubio R, Wang T, Agrawal D, McCarthy SM, Gruidl M, et al. Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue. Breast Cancer Res Treat 2010; 119:335 - 46; http://dx.doi.org/10.1007/s10549-009-0344-y; PMID: 19266279
  • Kokkinakis DM, Liu X, Neuner RD. Modulation of cell cycle and gene expression in pancreatic tumor cell lines by methionine deprivation (methionine stress): implications to the therapy of pancreatic adenocarcinoma. Mol Cancer Ther 2005; 4:1338 - 48; http://dx.doi.org/10.1158/1535-7163.MCT-05-0141; PMID: 16170025
  • Lauss M, Kriegner A, Vierlinger K, Visne I, Yildiz A, Dilaveroglu E, Noehammer C. Consensus genes of the literature to predict breast cancer recurrence. Breast Cancer Res Treat 2008; 110:235 - 44; http://dx.doi.org/10.1007/s10549-007-9716-3; PMID: 17899371
  • Stuart JE, Lusis EA, Scheck AC, Coons SW, Lal A, Perry A, Gutmann DH. Identification of gene markers associated with aggressive meningioma by filtering across multiple sets of gene expression arrays. J Neuropathol Exp Neurol 2011; 70:1 - 12; http://dx.doi.org/10.1097/NEN.0b013e3182018f1c; PMID: 21157382
  • Kretschmer C, Sterner-Kock A, Siedentopf F, Schoenegg W, Schlag PM, Kemmner W. Identification of early molecular markers for breast cancer. Mol Cancer 2011; 10:15; http://dx.doi.org/10.1186/1476-4598-10-15; PMID: 21314937
  • Cario G, Fetz A, Bretscher C, Möricke A, Schrauder A, Stanulla M, Schrappe M. Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia. Ann Hematol 2008; 87:709 - 16; http://dx.doi.org/10.1007/s00277-008-0504-x; PMID: 18521602
  • Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt MK, Dicks E, Dennis J, Wang Q, Humphreys MK, Luccarini C, et al, Netherlands Collaborative Group on Hereditary Breast and Ovarian Cancer (HEBON), Familial Breast Cancer Study (FBCS), Gene Environment Interaction of Breast Cancer in Germany (GENICA) Network, kConFab Investigators, Australian Ovarian Cancer Study Group. Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet 2012; 44:312 - 8; http://dx.doi.org/10.1038/ng.1049; PMID: 22267197
  • Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, Schmidt MK, Chang-Claude J, Bojesen SE, Bolla MK, et al, Breast and Ovarian Cancer Susceptibility Collaboration, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), kConFab Investigators, Australian Ovarian Cancer Study Group, GENICA (Gene Environment Interaction and Breast Cancer in Germany) Network. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 2013; 45:353 - 61, e1-2; http://dx.doi.org/10.1038/ng.2563; PMID: 23535729
  • Pujana MA, Han JD, Starita LM, Stevens KN, Tewari M, Ahn JS, Rennert G, Moreno V, Kirchhoff T, Gold B, et al. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet 2007; 39:1338 - 49; http://dx.doi.org/10.1038/ng.2007.2; PMID: 17922014
  • Zhang J, Lu K, Xiang Y, Islam M, Kotian S, Kais Z, Lee C, Arora M, Liu HW, Parvin JD, et al. Weighted frequent gene co-expression network mining to identify genes involved in genome stability. PLoS Comput Biol 2012; 8:e1002656; http://dx.doi.org/10.1371/journal.pcbi.1002656; PMID: 22956898
  • Kais Z, Barsky SH, Mathsyaraja H, Zha A, Ransburgh DJ, He G, Pilarski RT, Shapiro CL, Huang K, Parvin JD. KIAA0101 interacts with BRCA1 and regulates centrosome number. Mol Cancer Res 2011; 9:1091 - 9; http://dx.doi.org/10.1158/1541-7786.MCR-10-0503; PMID: 21673012
  • Bozdag D, Parvin JD, Catalyurek UV. A Biclustering Method to Discover Co-regulated Genes Using Diverse Gene Expression Datasets. Proceedings of First International Conference on Bioinformatics and Computational Biology (BICoB), LNCS 2009; 5462:151-63.
  • Eren K, Deveci M, Küçüktunç O, Çatalyürek UV. A comparative analysis of biclustering algorithms for gene expression data. Brief Bioinform 2013; 14:279 - 92; http://dx.doi.org/10.1093/bib/bbs032; PMID: 22772837
  • Pierce AJ, Johnson RD, Thompson LH, Jasin M. XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. Genes Dev 1999; 13:2633 - 8; http://dx.doi.org/10.1101/gad.13.20.2633; PMID: 10541549
  • Ransburgh DJ, Chiba N, Ishioka C, Toland AE, Parvin JD. Identification of breast tumor mutations in BRCA1 that abolish its function in homologous DNA recombination. Cancer Res 2010; 70:988 - 95; http://dx.doi.org/10.1158/0008-5472.CAN-09-2850; PMID: 20103620
  • Bennardo N, Cheng A, Huang N, Stark JM. Alternative-NHEJ is a mechanistically distinct pathway of mammalian chromosome break repair. PLoS Genet 2008; 4:e1000110; http://dx.doi.org/10.1371/journal.pgen.1000110; PMID: 18584027
  • Towler WI, Zhang J, Ransburgh DJ, Toland AE, Ishioka C, Chiba N, Parvin JD. Analysis of BRCA1 variants in double-strand break repair by homologous recombination and single-strand annealing. Hum Mutat 2013; 34:439 - 45; http://dx.doi.org/10.1002/humu.22251; PMID: 23161852
  • Starita LM, Machida Y, Sankaran S, Elias JE, Griffin K, Schlegel BP, Gygi SP, Parvin JD. BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number. Mol Cell Biol 2004; 24:8457 - 66; http://dx.doi.org/10.1128/MCB.24.19.8457-8466.2004; PMID: 15367667
  • Kais Z, Chiba N, Ishioka C, Parvin JD. Functional differences among BRCA1 missense mutations in the control of centrosome duplication. Oncogene 2012; 31:799 - 804; http://dx.doi.org/10.1038/onc.2011.271; PMID: 21725363
  • Sankaran S, Starita LM, Groen AC, Ko MJ, Parvin JD. Centrosomal microtubule nucleation activity is inhibited by BRCA1-dependent ubiquitination. Mol Cell Biol 2005; 25:8656 - 68; http://dx.doi.org/10.1128/MCB.25.19.8656-8668.2005; PMID: 16166645
  • Lingle WL, Salisbury JL. Methods for the analysis of centrosome reproduction in cancer cells. Methods Cell Biol 2001; 67:325 - 36; http://dx.doi.org/10.1016/S0091-679X(01)67022-5; PMID: 11550478
  • D’Assoro AB, Stivala F, Barrett S, Ferrigno G, Salisbury JL. GFP-centrin as a marker for centriole dynamics in the human breast cancer cell line MCF-7. Ital J Anat Embryol 2001; 106:Suppl 1 103 - 10; PMID: 11729945
  • Ruffner H, Verma IM. BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc Natl Acad Sci U S A 1997; 94:7138 - 43; http://dx.doi.org/10.1073/pnas.94.14.7138; PMID: 9207057
  • Choudhury AD, Xu H, Baer R. Ubiquitination and proteasomal degradation of the BRCA1 tumor suppressor is regulated during cell cycle progression. J Biol Chem 2004; 279:33909 - 18; http://dx.doi.org/10.1074/jbc.M403646200; PMID: 15166217
  • Jin Y, Xu XL, Yang MC, Wei F, Ayi TC, Bowcock AM, Baer R. Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains. Proc Natl Acad Sci U S A 1997; 94:12075 - 80; http://dx.doi.org/10.1073/pnas.94.22.12075; PMID: 9342365
  • Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998; 273:5858 - 68; http://dx.doi.org/10.1074/jbc.273.10.5858; PMID: 9488723
  • Bhattacharyya A, Ear US, Koller BH, Weichselbaum RR, Bishop DK. The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin. J Biol Chem 2000; 275:23899 - 903; http://dx.doi.org/10.1074/jbc.C000276200; PMID: 10843985
  • Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 2012; 490:61 - 70; http://dx.doi.org/10.1038/nature11412; PMID: 23000897
  • Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012; 2:401 - 4; http://dx.doi.org/10.1158/2159-8290.CD-12-0095; PMID: 22588877
  • Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013; 6:pl1; http://dx.doi.org/10.1126/scisignal.2004088; PMID: 23550210
  • Kotian S, Liyanarachchi S, Zelent A, Parvin JD. Histone deacetylases 9 and 10 are required for homologous recombination. J Biol Chem 2011; 286:7722 - 6; http://dx.doi.org/10.1074/jbc.C110.194233; PMID: 21247901

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.